ArticleInternal medicine (Tokyo, Japan)2025
Lorlatinib for the Treatment of Inflammatory Myofibroblastic Tumor after Allogeneic Hematopoietic Stem Cell Transplantation.
Toshinari Yagi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.